Massachusetts Financial Services Co. MA Sells 7,788 Shares of Teleflex Incorporated $TFX

Massachusetts Financial Services Co. MA reduced its holdings in Teleflex Incorporated (NYSE:TFX) by 1.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 610,933 shares of the medical technology company’s stock after selling 7,788 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Teleflex were worth $74,754,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its stake in Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares during the period. Thompson Investment Management Inc. lifted its holdings in shares of Teleflex by 2.1% during the second quarter. Thompson Investment Management Inc. now owns 4,970 shares of the medical technology company’s stock worth $588,000 after buying an additional 100 shares during the last quarter. CX Institutional boosted its position in shares of Teleflex by 14.7% in the second quarter. CX Institutional now owns 872 shares of the medical technology company’s stock valued at $103,000 after acquiring an additional 112 shares during the period. Parallel Advisors LLC boosted its position in shares of Teleflex by 43.1% in the second quarter. Parallel Advisors LLC now owns 455 shares of the medical technology company’s stock valued at $54,000 after acquiring an additional 137 shares during the period. Finally, Osaic Holdings Inc. grew its stake in shares of Teleflex by 17.5% in the second quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock worth $148,000 after acquiring an additional 186 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on TFX shares. Zacks Research cut shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Royal Bank Of Canada restated a “sector perform” rating and set a $135.00 price objective on shares of Teleflex in a report on Wednesday, December 17th. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Tuesday, December 9th. Finally, Truist Financial upped their price target on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a report on Thursday, December 18th. One investment analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Teleflex currently has a consensus rating of “Reduce” and a consensus target price of $142.43.

Teleflex Price Performance

NYSE:TFX opened at $100.26 on Wednesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The company has a 50-day moving average of $116.59 and a 200-day moving average of $120.34. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $185.94. The company has a market capitalization of $4.43 billion, a price-to-earnings ratio of -13.64, a PEG ratio of 1.34 and a beta of 0.93.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to analyst estimates of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The company’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.4%. The ex-dividend date was Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is -18.50%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.